Iron overload augments angiotensin II-induced cardiac fibrosis and promotes neointima formation

Circulation

Volumn 106, Issue 14, 2002, Pages 1840-1846

  Ishizaka, Nobukazu ^a   Saito, Kan ^a   Mitani, Haruo ^a   Yamazaki, Ieharu ^c   Sata, Masataka ^a   Usui, Shin Ichi ^a   Mori, Ichiro ^b   Ohno, Minoru ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c Inoue (Japan) Memorial Hospital   (Japan)

Author keywords

Angiotensin; Catecholamines; Oxygen; Stress

Indexed keywords

ANGIOTENSIN; DEFEROXAMINE; HEME OXYGENASE 1; NORADRENALIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; ELECTRON MICROSCOPY; HEART MUSCLE FIBROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFUSION; INTIMA; IRON CHELATION; IRON OVERLOAD; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FIBROSIS; HEART; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IRON CHELATING AGENTS; IRON OVERLOAD; IRON-DEXTRAN COMPLEX; LOSARTAN; MALE; MYOCARDIUM; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TUNICA INTIMA; VASODILATOR AGENTS;

EID: 0036789703     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000031161.77536.02     Document Type: Article

References (28)

1. Zainal TA, Weindruch R, Szweda LI, et al. Localization of 4-hydroxy-2-nonenal-modified proteins in kidney following iron overload. Free Radic Biol Med. 1999;26:1181-1193.
2. Olson LJ, Edwards WD, McCall JT, et al. Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol. 1987;10:1239-1243.
3. Buja LM, Roberts WC. Iron in the heart: etiology and clinical significance. Am J Med. 1971;51:209-221.
4. de Valk B, Marx JJ. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med. 1999;159:1542-1548.
5. Lee TS, Shiao MS, Pan CC, et al. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation. 1999;99:1222-1229.
6. Ishizaka N, Aizawa T, Yamazaki I, et al. Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration. Lab Invest. 2002;82:87-96.
7. Vile GF, Tyrrell RM. Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. J Biol Chem. 1993;268:14678-14681.
8. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103:129-135.
9. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A. 1997;94:10925-10930.
10. Ferris CD, Jaffrey SR, Sawa A, et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol. 1999;1:152-157.
11. Nath KA, Vercellotti GM, Grande JP, et al. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int. 2001;59:106-117.
12. Nath KA, Balla G, Vercellotti GM, et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest. 1992;90:267-270.
13. Ishizaka N, de Leon H, Laursen JB, et al. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation. 1997;96:1923-1929.
14. Ishizaka N, Aizawa T, Mori I, et al. Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am J Physiol Heart Circ Physiol. 2000;279:H672-H678.
15. Gottlieb RA, Engler RL. Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci. 1999;874:412-426.
16. Walter DH, Haendeler J, Galle J, et al. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation. 1998;98:1153-1157.
17. Santos MM, de Sousa M, Rademakers LH, et al. Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1. Am J Pathol. 2000;157:1883-1892.
18. Carthew P, Dorman BM, Edwards RE, et al. A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload. Lab Invest. 1993;69:217-222.
19. Yu CM, Tipoe GL, Wing-Hon Lai K, et al. Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol. 2001;38:1207-1215.
20. Harada K, Sugaya T, Murakami K, et al. Angiotensin II type IA receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction. Circulation. 1999;100:2093-2099.
21. Houglum K, Bedossa P, Chojkier M. TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am J Physiol. 1994;267:G908-G913.
22. Sia YT, Lapointe N, Parker TG, et al. Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. Circulation. 2002;105:2549-2555.
23. Misra HP, Rabideau C. Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals. Mol Cell Biochem. 2000;204:119-126.
24. Svegliati-Baroni G, Saccomanno S, van Goor H, et al. Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver. 2001;21:1-12.
25. Bruck R, Shirin H, Aeed H, et al. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J Hepatol. 2001;35:457-464.
26. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981;1:1293-1294.
27. Rosenthal EA, Bohlmeyer TJ, Monnet E, et al. An iron-binding exochelin prevents restenosis due to coronary artery balloon injury in a porcine model. Circulation. 2001;104:2222-2227.
28. Daemen MJ, Lombardi DM, Bosman FT, et al. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.